革蘭氏陽性菌細胞壁成分lipoteichoic acid引發上皮細胞環氧酵素-2表現的訊號傳遞路徑之探討

本論文主要在探討lipoteichoic acid (LTA) 刺激人類肺臟上皮細胞 (A549) cyclooxygenase (COX) 活性增加及 COX-2 表現的訊號傳遞路徑。LTA以濃度相關的方式刺激prostaglandin E2 (PGE2)的釋放、COX 活性的增加及COX-2的表現。當以 LTA 處理不同的時間，在外加 arachidonic acd (30 mM, 30 min)的情況下，發現 LTA 以時間相關的方式引發COX活性增加和COX-2的表現。而dexamethasone、蛋白轉錄抑制劑actinomycin D和蛋白轉譯抑制劑cycloheximide可抑制LTA 所引發之COX活性增加及 COX-2 的表現，然而內毒素的抑制劑polymyxin B 則不影響LTA所引發之反應。PC-PLC抑制劑D-609和phosphatidate phosphohydrolase抑制劑propranolol可抑制LTA 所引發之COX活性增加及 COX-2 表現，然而PI-PLC抑制劑U-73122則不影響LTA 所引發之反應。Go 6976、Ro 31-8220和GF 109203X三種PKC抑制劑顯著地抑制LTA所引發之COX活性增加及 COX-2 的表現。Ca2+ 的螯合劑BAPTA 也抑制LTA所引發之COX活性增加及 COX-2 的表現。先前的報告已證實A549細胞存在有PKC-a, -g, -i, -l, -z, -m 六種同功酵素。當以LTA刺激A549細胞發現在六種PKC isoforms中只有PKC-a 和-g 會從細胞質轉位到細胞核，這結果暗示PKC-a 和 -g 可能包含在LTA 引發 COX-2表現的訊號傳遞路徑。Adenylate cyclase抑制劑2,5-dideoxyadenosine (DDA) 及PKA抑制劑KT-5720和H-8可抑制LTA 所引發之 COX活性增加及 COX-2 表現。Tyrosine kinase 抑制劑genistein及tyrphostin AG126 可抑制LTA所引發之COX活性增加及 COX-2 的表現。MEK抑制劑PD 98059和p38 MAPK抑制劑SB 203580亦可抑制LTA刺激 COX-2 活性增加及 COX-2 的表現。LTA以劑量及時間相關的方式引發p44/42 MAPK之活化，當加入genistein、Ro 31-8220、SB 203580、PD 98059或KT-5720，發現genistein可部分抑制 LTA 所引發之 p44/42 MAPK的活化，PD 98059幾乎可完全的抑制LTA的作用，但Ro 31-8220、SB 203580及KT-5720 這些抑制劑則皆不會影響 LTA 的作用，表示 LTA 所引發之 p44/42 MAPK的活化可受到上游 tyrosine kinase之調控，但並不會受到PKC 、 PKA及p38 MAPK的調控。LTA也以劑量及時間相關的方式引發 p38 MAPK活性的增加，當加入 Ro 31-8220 、 genistein 、 PD 98059、 SB 203580 或 KT-5720，發現這些抑制劑，除了 PD 98059不影響LTA所引發之 p38 MAPK活性的增加，其他抑制劑則皆有抑制作用，表示LTA刺激p38 MAPK的活性增加可受到上游 PKC、tyrosine kinase及 PKA之調控，但並不會受到 MEK的調控。NF-κB 抑制劑 pyrrolidine dithiocarbamate (PDTC) 可抑制LTA所引發之COX活性增加及 COX-2 的表現。以 LTA 刺激細胞10分鐘可使p65 NF-κB 由細胞質轉位至細胞核，亦會造成IκB-α 在細胞質的分解，兩者反應皆在60分鐘後明顯地減少。Electrophoretic mobility shift assay (EMSA)的結果也發現LTA可使NF-κB 的活性隨作用時間而增加，於10分鐘時達最大反應，但60分鐘後反應明顯地減少，當加入Go 6976、Ro 31-8220、PDTC、KT-5720、genistein、PD 98059或SB 203580，發現這些抑制劑，除了KT-5720不影響LTA所刺激NF-κB活性的增加，其他抑制劑則皆有抑制作用，表示LTA刺激NF-κB活性的增加可受到上游 PKC、tyrosine kinase、MEK及p38 MAPK之調控，但並不會受到PKA的調控。綜合以上的結果得知，在A549細胞中，LTA至少經由三條訊號傳遞路徑調控COX-2的表現。

關鍵字

lipoteichoic acid ； cyclooxygenase ； signal transduction

並列摘要

The signal transduction pathway of lipoteichoic acid (LTA)-induced increase of cyclooxygenase (COX) activity and COX-2 expression was studied in human pulmonary epithelial cell line (A549). LTA caused a concentration-dependent increase in the accumulation of PGE2, increase of COX activity, and increase of COX-2 expression. The increase of COX activity in LTA-activated A549 cells was measured by the formation of PGE2 in the presence of arachidonic acid (30 μM; 30 min). LTA also caused a time- dependent increase in the COX activity, and COX-2 expression. Dexamethasone, actinomycin D and cycloheximide inhibited LTA-induced accumulation of COX activity and COX-2 expression. Polymyxin B, an agent which binds and inactivates endotoxin, did not affect LTA-induced increase of COX activity and COX-2 expression. The phosphatidylcholine-phospholipase C inhibitor (D-609) and phosphatidate phosphohydrolase inhibitor (propranolol) prevented LTA-induced increase of COX activity and COX-2 expression, while U-73122 (a phosphatidylinositol-phospholipase C inhibitor) had no effect. The PKC inhibitors (Go 6976, Ro 31-8220 and GF 109203X) and Ca2+ chelator (BAPTA) also attenuated LTA-induced increase of COX activity and COX-2 expression. In our previous studies have demonstrated that A549 cells expressed PKC-α, -γ, -ι, -λ, -z and -μ. Treatment of A549 cells with LTA caused the translocation of PKC-α and -γ but not other isoforms from cytosol to the membrane fraction, indicating activation of the PKC-α and -γ isoforms. In addition, the adenylate cyclase inhibitor, 2,5-dideoxyadenosine (DDA), and protein kinase A inhibitors, KT-5720 and H-8, prevented LTA-induced increase of COX activity and COX-2 expression. The LTA-induced the increase of COX activity and COX-2 expression were also inhibited by tyrosine kinase inhibitors (genistein and tyrphostin AG126). The MEK inhibitor (PD 98059) and p38 MAPK inhibitor (SB 203580) also prevented LTA-induced increase of COX activity and COX-2 expression. LTA caused a concentration- and time-dependent activation of p44/42 MAPK. Moreover, the LTA-induced p44/42 MAPK activation was inhibited by genistein or PD 98059, but not by Ro 31-8220, SB 203580 and KT-5720. LTA caused a concentration- and time-dependent increase in p38 MAPK activity. The LTA-induced p38 MAPK activation was inhibited by Ro 31-8220, genistein, SB 203580 and KT-5720, but not by PD 98059. Moreover, the NF-κB inhibitor, pyrrolidine dithiocarbamate (PDTC), attenuated LTA-induced increase of COX activity and COX-2 expression. Treatment of A549 cells with LTA for 10 min resulted in the translocation of p65 NF-κB from cytosol to the nucleus as well as the degradation of Iκ-Bα in the cytosol. NF-κB binding to DNA-protein was also enhanced by LTA. Go 6976, Ro 31-8220, PDTC, genistein, PD 98059 and SB 203580 all inhibited the DNA-protein binding activity stimulated by LTA, while KT-5720 had no effect. Taken together, these data indicate that in pulmonary epithelial cells, LTA regulates COX-2 expression by at least three distinct signaling pathways.

並列關鍵字

脂台口酸；環氧酵素；訊號傳遞

參考文獻

Akarasereenont, P. (1995) Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages. Eur. J. Pharmacol. 273, 121-128.

Akarasereenont, P. and Thiemermann C. (1996) The induction of cyclooxygenase-2 in human pulmonary epithelial cell culture (A549) activated by IL-1β is inhibited by tyrosine kinase inhibitors. Biochem. Biophy. Res. Com. 220, 181-185.

Albert, J., Polito, M.D. and David, P.B. (1998) Epithelial cells as regulators of airway inflammation. J.Allergy Clin. Immunol. 102, 714-718.

Asaoka, Y., Nakamura, S.I., Yoshida, K. and Nishizuka, Y. (1992) Protein kinase C, calcium and phospholipid degradation. Trends Biochem. Sci. 17, 414-417.

Baeurle, P.A. and Henkel, T. (1994) Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179.

國際替代計量

革蘭氏陽性菌細胞壁成分lipoteichoic acid引發上皮細胞環氧酵素-2表現的訊號傳遞路徑之探討

未授權

主題瀏覽